This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.90% per year. These returns cover a period from January 1, 1988 through December 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-consensus: Archive
JPMorgan Chase & Co. (JPM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
JPMorgan Chase & Co. (JPM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JPMNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
The Bank of New York Mellon Corporation (BK) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
The Bank of New York Mellon (BK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BKNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Delta Air Lines (DAL) Q4 Earnings Expected to Decline
by Zacks Equity Research
Delta (DAL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DALNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Does Slide Insurance Holdings, Inc. (SLDE) Have the Potential to Rally 25.27% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Slide Insurance Holdings, Inc. (SLDE) points to a 25.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
SLDENegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Dutch Bros (BROS) Have the Potential to Rally 29.09% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 29.1% upside potential for Dutch Bros (BROS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
BROSNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe American Superconductor (AMSC) Could Rally 86.69%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for American Superconductor (AMSC) points to an 86.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
AMSCNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 92.12% Upside in Ardelyx (ARDX): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 92.1% in Ardelyx (ARDX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
ARDXPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Kyndryl Holdings, Inc. (KD) Could Rally 43.07%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 43.1% in Kyndryl Holdings, Inc. (KD). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
KDNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Globale Online (GLBE) Have the Potential to Rally 27.21% as Wall Street Analysts Expect?
by Zacks Equity Research
The consensus price target hints at a 27.2% upside potential for Globale Online (GLBE). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
GLBENegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does Albertsons Companies (ACI) Have the Potential to Rally 36.33% as Wall Street Analysts Expect?
by Zacks Equity Research
The mean of analysts' price targets for Albertsons Companies (ACI) points to a 36.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
ACINegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Does APTIV HLDS LTD (APTV) Have the Potential to Rally 26.57% as Wall Street Analysts Expect?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 26.6% in APTIV HLDS LTD (APTV). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
APTVNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Allied Gold Corporation (AAUC) Could Rally 27.35%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 27.4% in Allied Gold Corporation (AAUC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
AAUCPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Believe Rayonier (RYN) Could Rally 25.87%: Here's is How to Trade
by Zacks Equity Research
The mean of analysts' price targets for Rayonier (RYN) points to a 25.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
RYNNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Predict a 29.99% Upside in Skyward (SKWD): Here's What You Should Know
by Zacks Equity Research
The consensus price target hints at a 30% upside potential for Skyward (SKWD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
SKWDNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Mitek Systems (MITK) Could Surge 32.9%: Read This Before Placing a Bet
by Zacks Equity Research
The mean of analysts' price targets for Mitek Systems (MITK) points to a 32.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
MITKNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Photronics (PLAB) Could Surge 29.39%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 29.4% upside potential for Photronics (PLAB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
PLABNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts Think Nuvation Bio (NUVB) Could Surge 32.05%: Read This Before Placing a Bet
by Zacks Equity Research
The consensus price target hints at a 32.1% upside potential for Nuvation Bio (NUVB). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
NUVBPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Earnings Preview: Kura Sushi (KRUS) Q1 Earnings Expected to Decline
by Zacks Equity Research
Kura Sushi (KRUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KRUSNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Analysts Estimate Jefferies (JEF) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Jefferies (JEF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JEFNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Earnings Preview: Constellation Brands (STZ) Q3 Earnings Expected to Decline
by Zacks Equity Research
Constellation Brands (STZ) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
STZPositive Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Franklin Covey (FC) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Franklin Covey (FC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
FCNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
AZZ (AZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
AZZ (AZZ) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AZZNegative Net Change
consensus-outlook earnings earnings-consensus earnings-esp earnings-estimates-revisions earnings-expectations earnings-preview stock-price-change zacks-consensus-estimate
Wall Street Analysts See a 68.54% Upside in WeRide Inc. (WRD): Can the Stock Really Move This High?
by Zacks Equity Research
The consensus price target hints at a 68.5% upside potential for WeRide Inc. (WRD). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
WRDNegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 60.47% Upside in Ooma (OOMA): Can the Stock Really Move This High?
by Zacks Equity Research
The mean of analysts' price targets for Ooma (OOMA) points to a 60.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
OOMANegative Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate
Wall Street Analysts See a 91.49% Upside in Contineum Therapeutics, Inc. (CTNM): Can the Stock Really Move This High?
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 91.5% in Contineum Therapeutics, Inc. (CTNM). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
CTNMPositive Net Change
earnings-consensus earnings-estimates-revisions zacks-consensus-estimate